Despite improvements in our understanding of pancreatic cancer and the emerging concept of personalized medicine for the treatment of this disease, it is still the fourth most common cause of cancer death in the western world. It is established that pancreatic cancer is a highly heterogeneous disease with a complex tumor microenvironment. Indeed the extensive stroma surrounding the cancer cells has been shown to be important in promoting tumor growth and metastases, as well as sequestering chemotherapeutic agents consequently decreasing delivery to the tumor cells. Nanotechnology has come to the forefront in the areas of medical diagnostics, imaging, and therapeutic drug delivery. This review will focus on the potential applications of nano...
Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the p...
Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and surviva...
Pancreatic adenocarcinoma has the worst outcome among all cancer types, with a 5-year survival rate ...
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognos...
As the increase in therapeutic and imaging technologies is swiftly improving survival chances for ca...
Pancreatic cancer (PC), one of the most lethal solid tumors in humans, has a five-year survival rate...
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognos...
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognos...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Despite improvements in surgical techniques and adjuvant chemotherapy, the overall mortality rates i...
Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is ...
Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is ...
In the last decades, extensive research has been carried out on the understanding and t...
Pancreatic cancer is one of the most malignant tumors with one of the worst survival rates due to it...
Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the p...
Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and surviva...
Pancreatic adenocarcinoma has the worst outcome among all cancer types, with a 5-year survival rate ...
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognos...
As the increase in therapeutic and imaging technologies is swiftly improving survival chances for ca...
Pancreatic cancer (PC), one of the most lethal solid tumors in humans, has a five-year survival rate...
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognos...
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognos...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited t...
Despite improvements in surgical techniques and adjuvant chemotherapy, the overall mortality rates i...
Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is ...
Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is ...
In the last decades, extensive research has been carried out on the understanding and t...
Pancreatic cancer is one of the most malignant tumors with one of the worst survival rates due to it...
Nanotechnology may hold the key to controlling many devastating diseases. In the fight against the p...
Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and surviva...
Pancreatic adenocarcinoma has the worst outcome among all cancer types, with a 5-year survival rate ...